Navigation Links
Jiangbo Pharmaceuticals Chairman to Ring NASDAQ Opening Bell on August 27, 2010
Date:8/25/2010

Jiangbo Pharmaceuticals Chairman to Ring NASDAQ Opening Bell on August 27, 2010 -- LAIYANG, China, Aug. 25 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Awards Click to view news release full screen  

Jiangbo Pharmaceuticals Chairman to Ring NASDAQ Opening Bell on August 27, 2010

 

LAIYANG, China, Aug. 25 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) (the "Company" or "Jiangbo"), today announced that Mr. Wubo Cao, the Company's Chairman, will ring the Opening Bell at the NASDAQ MarketSite in New York City on Friday, August 27, 2010 at 9:30 a.m. ET to celebrate the Company's listing on the NASDAQ Stock Market.

Jiangbo began trading on the NASDAQ Capital Market on June 8, 2010, under the ticker symbol "JGBO".

"Our Opening Bell ringing ceremony at the NASDAQ MarketSite marks the culmination of our efforts to list our shares on a world-class stock exchange," said Mr. Cao. "We appreciate the dedication of our shareholders, employees, board of directors, and advisors who have enabled us to reach this critical milestone as a public company."

A live webcast of the NASDAQ Opening Bell (starting from 9:20 a.m. ET) will be available at: http://www.nasdaq.com/about/marketsitetowervideo.asx .

About Jiangbo Pharmaceuticals, Inc.

Jiangbo Pharmaceuticals is engaged in the research, development, production, marketing and sales of pharmaceutical products in China. The Company's operations are located in Eastern China in an Economic Development Zone in Laiyang City, Shandong Province. Jiangbo produces both western and Chinese herbal-based medical drugs in tablet, capsule, granule, syrup and electuary (sticky syrup) form. For additional information, please visit the Company's website (http://www.jiangbopharma.com ).

Safe Harbor Statement

Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the Company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties. Actual results may differ materially from anticipated or predicted results, and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's ability to execute its strategic plan. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

For more information, please contact: Jiangbo Pharmaceuticals, Inc. Ms. Elsa Sung, CFO Phone: +1-954-903-9378 x2 Email: elsasung@jiangbo.com Web: http:// www.jiangbopharma.com CCG Investor Relations Mr. Crocker Coulson, President Phone: +1-646-213-1915 Email: crocker.coulson@ccgir.com Web: http://www.ccgirasia.com
'/>"/>

SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets
2. Jiangbo Pharmaceuticals to Attend Global Hunter Securities China Conference
3. Jiangbo Pharmaceuticals Announces the Appointment of New Chief Executive Officer
4. Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market
5. Jiangbo Pharmaceuticals Reports Results for Third Quarter of Fiscal Year 2010
6. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
7. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
8. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
9. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
10. Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
11. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 10, 2016  The Baylor ... received an in-kind gift from ... VeinViewer® Vision vein finder for the nursing ... students as they learn how to start ... with traditional technique. ...
(Date:2/10/2016)... , Feb. 10, 2016  LexisNexis® Risk ... technology, today announced the launch of LexisNexis ... solution that helps improve and optimize the quality ... of performance using severity-adjusted scores. By measuring provider ... critical solution to deliver better outcomes, improve the ...
(Date:2/10/2016)... 10, 2016 Convergence scenarios are ... various technologies that results in diverse solutions ... opportunities create a cyclical system where technology ... the development of new technologies. ... technology convergences, which are constantly fostering new ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... 2016 , ... Emergency rooms provide emergency care to stabilize critical health issues, ... with dental emergencies at risk of losing a tooth or their smiles. Dr. Marine ... Common dental emergencies include:, , Avulsed or knocked-out teeth , ...
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ... Care Association™ (ALCA) to conduct a survey that takes a closer look at cases ... illustrates the prevalence and causes of TBI among the aging population, and identifies the ...
(Date:2/10/2016)... ... , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on ... year ended December 31, 2015 on Monday, February 29, 2016 after the market closes. ... following the release at 4:30 PM ET. Investors interested in participating by phone are ...
(Date:2/10/2016)... ... 2016 , ... For additional information contact Phyllis Strupp 480-488-5858 , Brain improves ... The Ultimate Guide to Brain Training" by award-winning author Phyllis Strupp explains ... is March 16, 2016. A free review copy is available to the media ...
(Date:2/10/2016)... ... February 10, 2016 , ... IDEX Health & Science, ... stainless steel (PLS) columns combine the strength of traditional stainless steel with the ... biological samples while operating at ultra-high pressures of 20,000 psi. The higher operating ...
Breaking Medicine News(10 mins):